Computer-assisted Surgery: European Hotspot Opens in GermanyLEIPZIG, Germany - Surgery in Full HD: Leipzig is now home to the future of precise, efficient and safe high-tech surgery. The International Reference and Development Centre for Surgical Technology (IRDC) is implementing an innovative, comprehensive approach in specialty surgery. The OR system is the first to link and analyze all patient information, making it a true surgical assistant. While the minimally invasive procedure is transmitted to a surgical cockpit in Full-HD quality, detailed patient information is combined in the background - including prior diseases, inflammation markers, structures at risk, nerve conduction data and HD images from inside the body. Three-dimensional views allow perfect preparation for surgery. MarketsandMarkets: Top Ten Medical Device Technologies Market Worth $454.3 Billion by 2014WILMINGTON, Delaware - According to a new healthcare market research report ‘Global Top Ten Medical Device Technologies Market (2009 - 2014)’, published by MarketsandMarkets (www.marketsandmarkets.com) in 2009, the entire market for top ten medical device technologies is estimated to be approximately $454.3 billion, of which medical diagnostic devices technologies alone constitute about 40% of the entire market at approximately $177.8 billion. The market for drug delivery devices constituted an estimated $110.8 billion for the same period. vProtect Luminal Shield (TM) from Prescient Medical Receives CE MarkDOYLESTOWN, Pennsylvania - - Novel Self-Expanding Platform for Treatment of Coronary Artery Disease Receives European Regulatory Clearance First Swedish Patients Receive MitraClip(R) TherapyMENLO PARK, California - - Use of the MitraClip(R) System Continues to Expand in Europe AdvanDx Closes US$8 Million Financing Round and Elects New Board MemberWOBURN, Massachusetts and VEDBAEK, Denmark - - Financing provided by existing investors SLS Venture and LD Pensions Hypertronics Circular HyperGrip(R) Connectors Selected for Biosense Webster’s CARTO(R) 3 Navigation SystemHUDSON, Massachusetts - Hypertronics Corporation, a Smiths Interconnect business and world-leading provider of high performance interconnect solutions for the most demanding applications today announced that its HyperGrip(R) series circular connectors were selected by Biosense Webster, Inc. for its new CARTO(R) 3 Navigation System. Hypertronics HyperGrip (HG) series was chosen for its optimal signal reliability and ease of use as a push pull connector. Shire plc: Core Portfolio of Products Delivers 20% Sales GrowthLONDON - - 2009 Guidance Framework Reaffirmed Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the three months to June 30, 2009. Hoya Announces First Quarter Financial Results for FY2010TOKYO, Japan - HOYA Corporation today announced financial results for the first quarter ended June 30, 2009. Net sales were 94.9 billion yen for the quarter, a 27.0% decrease from 130.1 billion yen in the same period last year, and operating income was 9.2 billion yen, a 57.5% decrease from 21.8 billion yen in the same period last year, mainly due to order decrease and the impact of exchange rates. Since April, however, there has been a degree of recovery noted in orders, which resulted in an increase of both net sales and operating income compared to the fourth quarter FY2009 ended March 31, 2009. “Over the Next 2-3 Years We Will Leverage Developmental Capabilities and Explore In-licensing and a Co-development Model to Consolidate Our Presence in Japan” - Dr. Kailash Sharma, President, Japan Operations, Zydus CadilaTOKYO - With a business plan to launch 8-10 new products each year, Nippon Universal Pharmaceutical Co. Ltd., a subsidiary of the Zydus group, one of India’s leading integrated pharma companies & a global healthcare provider, is looking to give a big boost to its operations in the Japanese generic market which is still evolving. While the total pharma market in Japan is estimated at $ 60 bn the generic market is only about 6% of this in value terms and just 18% in volume, which is very low compared to highly genericised markets like USA and Europe. The awareness of generics in Japan is comparatively low and generics are still largely perceived as cheaper, low quality alternatives to patented drugs. The nationwide promotion and awareness campaign regarding the safety and efficacy of generics however is expected to change this perception and usage in future. PROTOMED SA Chooses HyperWorks to Simulate Implantable Medical DevicesTROY, Michigan and MARSEILLE, France - - CAE suite and use of finite element analysis streamline development processes in the development of medical devices BD Announces UK Launch of new BD Nexiva(TM) Closed IV Catheter System Designed to Help Protect Healthcare WorkersOXFORD, England - BD Medical, a segment of BD (Becton, Dickinson and Company), announced today the UK launch of the latest BD Nexiva(TM) Closed IV Catheter System designed to reduce healthcare workers’ risk of needlestick injuries and minimise exposure to blood. The system includes the BD Q-SyteTM Luer Access Split Septum to help reduce catheter-related bloodstream infections (CRBSIs). Merck Serono Submits Application for Cladribine Tablets as Multiple Sclerosis Therapy in EuropeGENEVA, Switzerland - Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the submission of a marketing authorization application (MAA) to the European Medicines Agency (EMEA) for Cladribine Tablets, Merck Serono’s proprietary investigational oral formulation of cladribine, as a therapy for patients with relapsing-remitting multiple sclerosis (MS). Cladribine Tablets could become the first orally administered disease-modifying therapy available for patients with MS, as all disease-modifying therapies currently approved for the treatment of MS are injectable. Growth in African Medical Imaging Markets: Frost & Sullivan Examines the PotentialCAPE TOWN, South Africa - Adverse economic conditions, the rising cost of healthcare and decreased donor funding to sub-Saharan Africa are posing major challenges to the medical imaging markets in many countries in the region. Price sensitivity and competition in these markets are expected to increase due to the current financial constraints faced by many healthcare institutions. Health Robotics to Launch Germany’s Installations of i.v.STATION(TM) at Charite-Universitatsmedizin BerlinBOZEN, Italy - Health Robotics today announced that it has signed a definitive agreement with Charite-Universitatsmedizin Berlin. Charite will install an i.v.STATION robot at its Centrum 14 during the second half of 2009. Pulmonx Announces New President and CEO Michael A. Baker to Lead Interventional Pulmonology CompanyREDWOOD CITY, California - Pulmonx, an emerging leader in interventional pulmonology and in the development of device therapies for the treatment of emphysema announced today that Michael A. Baker has joined the company as President and CEO and that he has been elected as a member of its board of directors. Apieron, Inc. Files Infringement Complaint Against Aerocrine AB, Aerocrine AG and Mr. Magnus PellesMENLO PARK, California - Today, Apieron, Inc. (www.apieron.com/) reported that it filed a patent infringement complaint against Aerocrine AB, Solna, Sweden, Aerocrine AG, Bad Homburg, Germany and Mr. Magnus Pelles, Usingen, Germany in the Regional Court of Mannheim, Germany. Apieron, makers of the Insight(TM) eNO System for measurement of exhaled nitric oxide, presented this complaint against Aerocrine on the grounds that they are offering and putting on the market portable and stationary analyzers to detect the nitric oxide content in breath, which Apieron considers to be infringing the German part of its European Patent EP 0 892 926. Gerresheimer Holds its own in Difficult EnvironmentDÜSSELDORF, Germany - - Sales in the First Half of 2009 (Excluding Technical Plastics) at Prior Year Level Accumetrics’ VerifyNow(R) P2Y12 Test Provides Physicians With Information to Assess a Patient’s Response to Newly-Approved Prasugrel (Effient(R))SAN DIEGO, California - With the recent FDA approval of the new P2Y12 inhibitor, prasugrel (Effient), Accumetrics, Inc. announces that its VerifyNow P2Y12 Test is not only able to assess response to Plavix(R), but also its newly approved competitor, Effient. In obtaining a result from the VerifyNow System, physicians are provided objective information to determine the response of an individual patient to their antiplatelet therapy, regardless of the P2Y12 inhibitor that is prescribed. World’s First Deep Brain Stimulation Device Approved for Treatment of Psychiatric Condition in EuropeTOLOCHENAZ, Switzerland - - CE Mark Approval for Medtronic’s Reclaim(R) DBS Therapy for Treatment of Chronic, Severe Obsessive-Compulsive Disorder Bayer Unveils DIDGET(TM), the First and Only Blood Glucose Meter That Connects With the Nintendo DS(TM) or DS(TM) LiteNEWBURY, England - - New DIDGET Meter Transforms Kids Diabetes Experience by Tapping Into Their Passion for Video Games to Build Consistent Blood Glucose Testing Habits Medical Imaging Modality Vendors Should Focus on Innovation and Alliances with Market Leaders, Advises Frost & SullivanLONDON - The market for most medical imaging devices is at a mature phase. Most unit shipment sales are geared towards the replacement of older systems. Global conglomerates, which have a combined market share of about 80 per cent, dominate the market. However, there are many small regional vendors that have carved out a significant presence in the medical imaging industry in Europe. Innovation will be critical for success in this market. Trimega Laboratories: Drunk Parents Risk Losing Children in Hair TestsLONDON - - With Photo Divorcing parents who embark on a hedonistic lifestyle are in danger of losing custody of their children thanks to a growing trend in hair test requests to gauge how often they get drunk. Frost & Sullivan Identifies Innovative and Cost-Effective Technology as Key Competitive Factor in European Medical Device MarketLONDON - The medical device industry is one of the most vital and dynamic sectors of the European economy. The industry is constantly driven by R&D, which needs to keep pace with the evolving demands of the medical fraternity. Gerresheimer Sells Technical Plastics BusinessDUSSELDORF, Germany - Gerresheimer AG, a leading manufacturer of glass and plastic products for the pharma & life science industry, has sold its Technical Plastics operations, which are not part of the MDAX company’s core business, to the FBH Group, Bad Soden, Germany. “Through the sale of the Technical Plastics segment Gerresheimer has - as formerly announced - taken a further step in its focus on the core business of pharma & life science,” says Dr. Axel Herberg, CEO of Gerresheimer AG. Frost & Sullivan European Gastroenterology Technology Implementation of the Year Award Bestowed on CrosponLONDON - The Frost & Sullivan “2009 European Gastroenterology Technology Implementation of the Year Award,” is presented to Ireland-based Crospon for successfully using the impedance planimetry technique in its novel EndoFLIP(R) (endoluminal functional lumen imaging probe) imaging system. Simbionix Signs Agreement With the European Association for Endoscopic SurgeryPRAGUE - Prague Convention Center - Simbionix and the European Association for Endoscopic Surgery (EAES) have signed an agreement to collaborate on the development of training materials and assessment tools for a new Laparoscopic Skills Curriculum. MEDRAD Multi Vendor Service Launches TotalRepair(SM) in EuropeMAASTRICHT, Netherlands - - The first and only guaranteed ultrasound probe repair solution makes efficient use of shrinking healthcare budgets Health Robotics Announces i.v.STATION(TM) Contract With Grifols in Spain, Portugal and South AmericaBOZEN , Italy - Health-Robotics today announced that it has signed an exclusive 5-year strategic partnership with Grifols S.A., the leading Pharmacy Automation provider in Spain, Portugal, and South America. Grifols desires to safely, accurately, and cost-effectively automate the preparation of non-hazardous IV Admixtures with Health Robotics’ i.v.STATION Robot. As part of this strategic partnership, Grifols will take delivery of 120 i.v.STATION Robots between now and December 2014 for deployment in Spain, Portugal, Chile, Brazil, Argentina, Uruguay, Paraguay, Peru, Ecuador, Bolivia, Venezuela, Colombia, Honduras, Costa Rica, Panama, El Salvador, Nicaragua, Guatemala, Surinam, Guyana, Belize, and French Guyana. LAP-BAND(TM) is First Obesity Intervention Device in Europe Indicated for Weight Loss That Improves or Leads to Remission of Type 2 DiabetesLONDON - - Medical Experts Call for Greater Consideration of Gastric Banding for Obese People With Type 2 Diabetes Agendia’s Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus RecommendationsHUNTINGTON BEACH, California and AMSTERDAM - International Expert Panel Recommends Use of Multigene Profiling Assays and Finds Intermediate Scores Lack Clinical Utility Biosense Webster to Showcase CARTO(R) 3 System at EurospaceBERLIN - State-of-the-Art Navigational Mapping System Offers Unique Combination of Accuracy, Speed and Efficiency Jolife AB Announces Launch of LUCAS(TM)2, the New Generation of LUCAS Chest Compression System, in Europe and CanadaLUND, Sweden - Now Electrically Powered, the Life-Saving Medical Device Offers the Most Lightweight and Compact Solution to Maintain Circulation in Cardiac Arrest Patients /C O R R E C T I O N — Biosense Webster, Inc./BERLIN - In the news release, “Biosense Webster to Showcase CARTO(R) 3 System at Eurospace” issued on 22 Jun 2009 09:31 GMT, by Biosense Webster, Inc. over PR Newswire, we are advised by a representative of the company that in the headline “Eurospace” should have been written as “Europace”. The correct headline therefore should have read “Biosense Webster to Showcase CARTO(R) 3 System at Europace”. Turkish Ministry of Health Purchases Two CyberKnife(R) SystemsSUNNYVALE, California - Expands Patient Access to the Benefits of Whole Body Radiosurgery Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the Turkish Ministry of Health has purchased two CyberKnife(R) Robotic Radiosurgery Systems for installation in Ankara and Istanbul, Turkey. Clinical and Histopathological Results Using Pollogen’s TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser TherapyTEL AVIV, Israel - In-vivo Clinical Study Confirms the Efficacy of TriPollar(TM) Technology for Reducing Fat and neo Collagen Generation |
